Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Hematology Therapies Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Hematology Therapies Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Hematology Therapies Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Hematology Instruments
    • 1.4.3 Hematology Consumables
  • 1.5 Market by Application
    • 1.5.1 Global Hematology Therapies Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostic Laboratories
    • 1.5.3 Hospitals and Clinics
    • 1.5.4 Academic Institutes
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Hematology Therapies Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Hematology Therapies Industry
      • 1.6.1.1 Hematology Therapies Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Hematology Therapies Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Hematology Therapies Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Hematology Therapies Market Perspective (2015-2026)
  • 2.2 Hematology Therapies Growth Trends by Regions
    • 2.2.1 Hematology Therapies Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Hematology Therapies Historic Market Share by Regions (2015-2020)
    • 2.2.3 Hematology Therapies Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Hematology Therapies Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Hematology Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Hematology Therapies Players by Market Size
    • 3.1.1 Global Top Hematology Therapies Players by Revenue (2015-2020)
    • 3.1.2 Global Hematology Therapies Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Hematology Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Hematology Therapies Market Concentration Ratio
    • 3.2.1 Global Hematology Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Hematology Therapies Revenue in 2019
  • 3.3 Hematology Therapies Key Players Head office and Area Served
  • 3.4 Key Players Hematology Therapies Product Solution and Service
  • 3.5 Date of Enter into Hematology Therapies Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Hematology Therapies Historic Market Size by Type (2015-2020)
  • 4.2 Global Hematology Therapies Forecasted Market Size by Type (2021-2026)

5 Hematology Therapies Breakdown Data by Application (2015-2026)

  • 5.1 Global Hematology Therapies Market Size by Application (2015-2020)
  • 5.2 Global Hematology Therapies Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Hematology Therapies Market Size (2015-2020)
  • 6.2 Hematology Therapies Key Players in North America (2019-2020)
  • 6.3 North America Hematology Therapies Market Size by Type (2015-2020)
  • 6.4 North America Hematology Therapies Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Hematology Therapies Market Size (2015-2020)
  • 7.2 Hematology Therapies Key Players in Europe (2019-2020)
  • 7.3 Europe Hematology Therapies Market Size by Type (2015-2020)
  • 7.4 Europe Hematology Therapies Market Size by Application (2015-2020)

8 China

  • 8.1 China Hematology Therapies Market Size (2015-2020)
  • 8.2 Hematology Therapies Key Players in China (2019-2020)
  • 8.3 China Hematology Therapies Market Size by Type (2015-2020)
  • 8.4 China Hematology Therapies Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Hematology Therapies Market Size (2015-2020)
  • 9.2 Hematology Therapies Key Players in Japan (2019-2020)
  • 9.3 Japan Hematology Therapies Market Size by Type (2015-2020)
  • 9.4 Japan Hematology Therapies Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Hematology Therapies Market Size (2015-2020)
  • 10.2 Hematology Therapies Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Hematology Therapies Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Hematology Therapies Market Size by Application (2015-2020)

11 India

  • 11.1 India Hematology Therapies Market Size (2015-2020)
  • 11.2 Hematology Therapies Key Players in India (2019-2020)
  • 11.3 India Hematology Therapies Market Size by Type (2015-2020)
  • 11.4 India Hematology Therapies Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Hematology Therapies Market Size (2015-2020)
  • 12.2 Hematology Therapies Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Hematology Therapies Market Size by Type (2015-2020)
  • 12.4 Central & South America Hematology Therapies Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Abbott Laboratories Company Details
    • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 13.1.3 Abbott Laboratories Hematology Therapies Introduction
    • 13.1.4 Abbott Laboratories Revenue in Hematology Therapies Business (2015-2020))
    • 13.1.5 Abbott Laboratories Recent Development
  • 13.2 Bio-Rad Laboratories
    • 13.2.1 Bio-Rad Laboratories Company Details
    • 13.2.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 13.2.3 Bio-Rad Laboratories Hematology Therapies Introduction
    • 13.2.4 Bio-Rad Laboratories Revenue in Hematology Therapies Business (2015-2020)
    • 13.2.5 Bio-Rad Laboratories Recent Development
  • 13.3 Roche
    • 13.3.1 Roche Company Details
    • 13.3.2 Roche Business Overview and Its Total Revenue
    • 13.3.3 Roche Hematology Therapies Introduction
    • 13.3.4 Roche Revenue in Hematology Therapies Business (2015-2020)
    • 13.3.5 Roche Recent Development
  • 13.4 HORIBA
    • 13.4.1 HORIBA Company Details
    • 13.4.2 HORIBA Business Overview and Its Total Revenue
    • 13.4.3 HORIBA Hematology Therapies Introduction
    • 13.4.4 HORIBA Revenue in Hematology Therapies Business (2015-2020)
    • 13.4.5 HORIBA Recent Development
  • 13.5 Beckman Coulter
    • 13.5.1 Beckman Coulter Company Details
    • 13.5.2 Beckman Coulter Business Overview and Its Total Revenue
    • 13.5.3 Beckman Coulter Hematology Therapies Introduction
    • 13.5.4 Beckman Coulter Revenue in Hematology Therapies Business (2015-2020)
    • 13.5.5 Beckman Coulter Recent Development
  • 13.6 Bayer
    • 13.6.1 Bayer Company Details
    • 13.6.2 Bayer Business Overview and Its Total Revenue
    • 13.6.3 Bayer Hematology Therapies Introduction
    • 13.6.4 Bayer Revenue in Hematology Therapies Business (2015-2020)
    • 13.6.5 Bayer Recent Development
  • 13.7 Sysmex
    • 13.7.1 Sysmex Company Details
    • 13.7.2 Sysmex Business Overview and Its Total Revenue
    • 13.7.3 Sysmex Hematology Therapies Introduction
    • 13.7.4 Sysmex Revenue in Hematology Therapies Business (2015-2020)
    • 13.7.5 Sysmex Recent Development
  • 13.8 Ortho Clinical Diagnostic
    • 13.8.1 Ortho Clinical Diagnostic Company Details
    • 13.8.2 Ortho Clinical Diagnostic Business Overview and Its Total Revenue
    • 13.8.3 Ortho Clinical Diagnostic Hematology Therapies Introduction
    • 13.8.4 Ortho Clinical Diagnostic Revenue in Hematology Therapies Business (2015-2020)
    • 13.8.5 Ortho Clinical Diagnostic Recent Development
  • 13.9 Siemens Healthineers
    • 13.9.1 Siemens Healthineers Company Details
    • 13.9.2 Siemens Healthineers Business Overview and Its Total Revenue
    • 13.9.3 Siemens Healthineers Hematology Therapies Introduction
    • 13.9.4 Siemens Healthineers Revenue in Hematology Therapies Business (2015-2020)
    • 13.9.5 Siemens Healthineers Recent Development
  • 13.10 HemoCue
    • 13.10.1 HemoCue Company Details
    • 13.10.2 HemoCue Business Overview and Its Total Revenue
    • 13.10.3 HemoCue Hematology Therapies Introduction
    • 13.10.4 HemoCue Revenue in Hematology Therapies Business (2015-2020)
    • 13.10.5 HemoCue Recent Development
  • 13.11 Boule Diagnostics
    • 10.11.1 Boule Diagnostics Company Details
    • 10.11.2 Boule Diagnostics Business Overview and Its Total Revenue
    • 10.11.3 Boule Diagnostics Hematology Therapies Introduction
    • 10.11.4 Boule Diagnostics Revenue in Hematology Therapies Business (2015-2020)
    • 10.11.5 Boule Diagnostics Recent Development
  • 13.12 EKF Diagnostics
    • 10.12.1 EKF Diagnostics Company Details
    • 10.12.2 EKF Diagnostics Business Overview and Its Total Revenue
    • 10.12.3 EKF Diagnostics Hematology Therapies Introduction
    • 10.12.4 EKF Diagnostics Revenue in Hematology Therapies Business (2015-2020)
    • 10.12.5 EKF Diagnostics Recent Development
  • 13.13 Drew Scientific
    • 10.13.1 Drew Scientific Company Details
    • 10.13.2 Drew Scientific Business Overview and Its Total Revenue
    • 10.13.3 Drew Scientific Hematology Therapies Introduction
    • 10.13.4 Drew Scientific Revenue in Hematology Therapies Business (2015-2020)
    • 10.13.5 Drew Scientific Recent Development
  • 13.14 Mindray Medical
    • 10.14.1 Mindray Medical Company Details
    • 10.14.2 Mindray Medical Business Overview and Its Total Revenue
    • 10.14.3 Mindray Medical Hematology Therapies Introduction
    • 10.14.4 Mindray Medical Revenue in Hematology Therapies Business (2015-2020)
    • 10.14.5 Mindray Medical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hematology Therapies market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Hematology Therapies industry.
    Based on our recent survey, we have several different scenarios about the Hematology Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Hematology Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hematology Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hematology Therapies market in terms of revenue.
    Players, stakeholders, and other participants in the global Hematology Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Hematology Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Hematology Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hematology Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hematology Therapies market.
    The following players are covered in this report:
    Abbott Laboratories
    Bio-Rad Laboratories
    Roche
    HORIBA
    Beckman Coulter
    Bayer
    Sysmex
    Ortho Clinical Diagnostic
    Siemens Healthineers
    HemoCue
    Boule Diagnostics
    EKF Diagnostics
    Drew Scientific
    Mindray Medical
    Hematology Therapies Breakdown Data by Type
    Hematology Instruments
    Hematology Consumables
    Hematology Therapies Breakdown Data by Application
    Diagnostic Laboratories
    Hospitals and Clinics
    Academic Institutes
    Others

    Buy now